Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Nuveen Asset Management LLC

Novavax call volume above normal and directionally bullish | Markets Insider

Novavax (NASDAQ:NVAX) Trading Down 5.4% - Time to Sell?

Deutsche Bank AG Increases Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)

Two Sigma Advisers LP Sells 1,219,700 Shares of Novavax, Inc. (NASDAQ:NVAX)

Millennium Management LLC Reduces Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Target of Unusually Large Options Trading (NASDAQ:NVAX)

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts

Analysts Think These Stocks Could More Than Double in Value

Twinbeech Capital LP Takes Position in Novavax, Inc. (NASDAQ:NVAX)

FDA Panel Recommends Monovalent COVID Vaccine for Next Season | MedPage Today

Top Medical Stocks To Consider - May 19th
BofA Reiterates Hold Rating on Novavax (NVAX) Stock

Reviewing REGENXBIO (NASDAQ:RGNX) and Novavax (NASDAQ:NVAX)

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

Healthy Returns: Novavax wins narrower Covid shot approval after delay

No Trial Data, No Vax: FDA Demands Gold Standard Testing For Any New COVID-19 Vaccines | ZeroHedge

Tang Capital Management LLC Sells 400,000 Shares of Novavax, Inc. (NASDAQ:NVAX)
Novavax, Inc. (NASDAQ:NVAX) Shares Fly 29% But Investors Aren't Buying For Growth - Simply Wall St News

Health Care Climbs as UnitedHealth Rebounds - Health Care Roundup | Morningstar

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

Novavax (NASDAQ:NVAX) Shares Gap Up - Should You Buy?

Novavax wins FDA nod for COVID-19 vaccine | BioWorld
International business briefs: US approves Novavax's Covid-19 vaccine

Novavax Working With Sanofi to Assess Funding After FDA Approval

Novavax Says FDA Approves BLA For COVID-19 Vaccine Nuvaxovid

Novavax Soars After Covid Vaccine Secures Full FDA Approval

Sanofi Invests $55.32 Million in Novavax, Inc. (NASDAQ:NVAX)

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine | Morningstar
Trending tickers: Nvidia, Alibaba, Novavax, Ryanair and Diageo

FDA Approves Novavax's Covid-19 Vaccine (May 16)

With FDA vaccine nod, Novavax takes ACIP of new COVID-19 rules | BioWorld

FDA Clears Novavax, Inc. (NVAX)'s COVID-19 Vaccine with Usage Restrictions

FDA Approves Nuvaxovid (COVID-19 Vaccine, Adjuvanted) to Prevent COVID-19

FDA nod for Novavax Covid vax, with stricter new conditions - Times of India

FDA approves Novavax COVID-19 vaccine with restrictions | Markets Insider

US FDA approves Novavax Covid vaccine with added conditions for use | World News - Business Standard

After delay, FDA approves Novavax's Covid-19 vaccine, but only for older people and those at high risk | CNN

FDA approves Novavax COVID vaccine with new conditions - The Economic Times
US health authorities to stop recommending Covid shots for children, pregnant women, WSJ reports

Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Estimates By $2.74 EPS

Novavax (NASDAQ:NVAX) Issues Earnings Results, Beats Expectations By $2.74 EPS

Novavax (NASDAQ:NVAX) Releases Earnings Results, Beats Expectations By $2.74 EPS

67,644 Shares in Novavax, Inc. (NASDAQ:NVAX) Acquired by Raymond James Financial Inc.

BioAtla (NASDAQ:BCAB) & Novavax (NASDAQ:NVAX) Head-To-Head Comparison

JP Morgan Lowers Price Target for NVAX, Maintains Underweight Rating | NVAX Stock News

'Show me the data': FDA commissioner reacts to question about Covid vaccine for young Americans

Novavax (NVAX) Faces Price Target Cut Amid Regulatory Concerns | NVAX Stock News

Decoding Novavax Inc (NVAX): A Strategic SWOT Insight

Appointments and advancements for May 9, 2025 | BioWorld

Novavax (NVAX) Eyes Resolution with FDA for Covid Vaccine Approval | NVAX Stock News

Moderna (MRNA) and Pfizer/BioNTech Vaccines Under FDA Review

Novavax (NVAX) Sets Sights on Profitability with Strategic Shifts

Novavax (NVAX) Shares Surge After Upbeat Q1 Results and Raised Revenue Outlook

Novavax Inc. Q1 2025 Earnings: EPS of $0.71, Revenue Surges to $667 Million, Exceeding Estimates

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights | NVAX Stock News

Novavax (NVAX) Reports Strong Q1 Earnings Boosted by APA Termina

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights | Morningstar

Novavax Q1 25 Earnings Conference Call At 8:30 AM ET

NVAX Earnings Report on 5/8/2025

Novavax to Participate in BofA Securities 2025 Health Care Conference | NVAX Stock News

Novavax to Participate in BofA Securities 2025 Health Care Conference | Morningstar